Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer - Concepedia

Concepedia

Publication | Open Access

Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer

DOI Full Paper Access

62

Citations

36

References

2023

Year

Cecilia Monge, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M. Hernandez, Bradford J. Wood, Elliot Levy, Israa Juburi,

Journal for ImmunoTherapy of Cancer

Abstract

NCT03206073.

References

	Year	Citations

Page 1